Karim Fizazi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Topics

Benign Prostatic Hyperplasia

Radical Prostatectomy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

Nature medicine

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Karim Fizazi, Gwénaël Le Teuff, Aude Fléchon, Lance Pagliaro, Josef Mardiak, Lionnel Geoffrois, Brigitte Laguerre, Christine Chevreau, Remy Delva, Frédéric Rolland, Christine Theodore, Guilhem Roubaud, Gwenaëlle Gravis, Jean-Christophe Eymard, Mathilde Cancel, Beata Juzyna, Maria Reckova, Natacha Naoun, Christopher Logothetis, Stephane Culine
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Emmanuel S Antonarakis, Nicole Zhang, Jayati Saha, Liina Nevalaita, Tarja Ikonen, L Jill Tsai, Chris Garratt, Karim Fizazi
Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Karim Fizazi, Arun A Azad, Nobuaki Matsubara, Joan Carles, Andre P Fay, Ugo De Giorgi, Jae Young Joung, Peter C C Fong, Eric Voog, Robert J Jones, Neal D Shore, Curtis Dunshee, Stefanie Zschäbitz, Jan Oldenburg, Dingwei Ye, Xun Lin, Cynthia G Healy, Nicola Di Santo, A Douglas Laird, Fabian Zohren, Archana M Agarwal
Publisher Correction: First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial. Nature medicine (2024)
Javier Carmona, Elena Chavarria, Kate Donoghue, Christina von Gertten, Petra Oberrauch, Emma Pailler, Giovanni Scoazec, Ruud Weijer, Judith Balmaña, Irene Brana, Cinzia Brunelli, Suzette Delaloge, Marc Deloger, Pierre Delpy, Ingemar Ernberg, Rebecca C Fitzgerald, Elena Garralda, Martin Lablans, Janne Lehtiö, Carlos Lopez, Maialen Fernández, Rosalba Miceli, Paolo G Nuciforo, Raquel Perez-Lopez, Elena Provenzano, Marjanka K Schmidt, Cesar Serrano, Neeltje Steeghs, David Tamborero, Valtteri Wirta, Richard D Baird, Karen Barker, Fabrice Barlesi, Michael Baumann, Jonas Bergh, Filippo G De Braud, Karim Fizazi, Stefan Fröhling, Alejandro Piris-Giménez, Kenneth Seamon, Michiel S Van Der Heijden, Wilbert Zwart, Josep Tabernero
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally. Cancer discovery 14 (7) (2024)
Aurore Carrot, Stéphane Oudard, Olivier Colomban, Karim Fizazi, Denis Maillet, A Oliver Sartor, Gilles Freyer, Benoit You
Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA. JCO clinical cancer informatics 8 (2024)
Javier Carmona, Elena Chavarria, Kate Donoghue, Christina von Gertten, Petra Oberrauch, Emma Pailler, Giovanni Scoazec, Ruud Weijer, Judith Balmaña, Irene Brana, Cinzia Brunelli, Suzette Delaloge, Marc Deloger, Pierre Delpy, Ingemar Ernberg, Rebecca C Fitzgerald, Elena Garralda, Martin Lablans, Janne Lehtiö, Carlos Lopez, Maialen Fernández, Rosalba Miceli, Paolo G Nuciforo, Raquel Perez-Lopez, Elena Provenzano, Marjanka K Schmidt, Cesar Serrano, Neeltje Steeghs, David Tamborero, Valtteri Wirta, Richard D Baird, Karen Barker, Fabrice Barlesi, Michael Baumann, Jonas Bergh, Filippo G De Braud, Karim Fizazi, Stefan Fröhling, Alejandro Piris-Giménez, Kenneth Seamon, Michiel S Van Der Heijden, Wilbert Zwart, Josep Tabernero
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally. Cancer discovery (2024)
Aurore Carrot, Stéphane Oudard, Olivier Colomban, Karim Fizazi, Denis Maillet, A Oliver Sartor, Gilles Freyer, Benoit You
Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA. JCO clinical cancer informatics 8 (2024)
Emmanuel S Antonarakis, Nicole Zhang, Jayati Saha, Liina Nevalaita, Tarja Ikonen, L Jill Tsai, Chris Garratt, Karim Fizazi
Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Maha H A Hussain, Bertrand Tombal, Fred Saad, Karim Fizazi, Cora N Sternberg, E David Crawford, Neal D Shore, Evgeny Kopyltsov, Arash Rezazadeh Kalebasty, Martin Boegemann, Dingwei Ye, Felipe José Silva Melo Cruz, Hiroyoshi Suzuki, Shivani Kapur, Shankar Srinivasan, Frank Verholen, Iris Kuss, Heikki Joensuu, Matthew R Smith
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Joan Carles, Rafael Antonio Medina-López, Javier Puente Vázquez, Álvaro Gómez-Ferrer, Francisco Javier Casas-Nebra, María Isabel Sáez Medina, Maria J Ribal, Alfredo Rodríguez Antolín, José Luís Álvarez-Ossorio, José Francisco Suárez Novo, Cristina Moretones Agut, Shankar Srinivasan, Jorge Ortiz, Karim Fizazi
Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis. Future oncology (London, England) (2023)
Joaquin Mateo, Johann S de Bono, Karim Fizazi, Fred Saad, Neal D Shore, Shahneen Sandhu, Kim N Chi, Archana M Agarwal, David Olmos, Antoine Thiery-Vuillemin, Mustafa Özgüroğlu, Niven Mehra, Nobuaki Matsubara, Jae Young Joung, Charles Padua, Ernesto Korbenfeld, Jinyu Kang, Helen Marshall, Zhongwu Lai, Alan Barnicle, Christian Poehlein, Natalia Lukashchuk, Maha H A Hussain
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Naoual Menssouri, Loic Poiraudeau, Carole Helissey, Ludovic Bigot, Jonathan Sabio, Tony Ibrahim, Cedric Pobel, Claudio Nicotra, Maud Ngo-Camus, Ludovic Lacroix, Etienne Rouleau, Lambros Tselikas, Anne Chauchereau, Félix Blanc-Durand, Alice Bernard-Tessier, Anna Patrikidou, Natacha Naoun, Ronan Flippot, Emeline Colomba, Alina Fuerea, Laurence Albiges, Pernelle Lavaud, Paul van de Wiel, Eveline den Biezen-Timmermans, Yvonne J W Rozendaal, Santiago Ponce-Aix, Stefan Michiels, Christophe Massard, Daniel Gautheret, Fabrice Barlesi, Fabrice Andre, Benjamin Besse, Jean Yves Scoazec, Luc Friboulet, Karim Fizazi, Yohann Loriot
Genomic profiling of metastatic castration-resistant prostate cancer samples resistant to androgen-receptor pathway inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Susan Halabi, Qian Yang, Akash Roy, Bin Luo, John C Araujo, Christopher Logothetis, Cora N Sternberg, Andrew J Armstrong, Michael A Carducci, Kim N Chi, Johann S de Bono, Daniel P Petrylak, Karim Fizazi, Celestia S Higano, Michael J Morris, Dana E Rathkopf, Fred Saad, Charles J Ryan, Eric J Small, William Kevin Kelly
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Luca Antonelli, Davide Ardizzone, Isamu Tachibana, Nabil Adra, Clint Cary, Lee Hugar, Wade J Sexton, Aditya Bagrodia, Michal Mego, Siamak Daneshmand, Nicola Nicolai, Sebastiano Nazzani, Patrizia Giannatempo, Andrea Franza, Axel Heidenreich, Pia Paffenholz, Ragheed Saoud, Scott E Eggener, Matthew Ho, Nathaniel Oswald, Kathleen Olson, Alexey A Tryakin, Mikhail Yu Fedyanin, Natacha Naoun, Christophe Javaud, Walter Cazzaniga, David Nicol, Axel Gerdtsson, Torgrim Tandstad, Karim Fizazi, Christian Daniel Fankhauser, null null
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Karim Fizazi, Arun A Azad, Nobuaki Matsubara, Joan Carles, Andre P Fay, Ugo De Giorgi, Jae Young Joung, Peter C C Fong, Eric Voog, Robert J Jones, Neal D Shore, Curtis Dunshee, Stefanie Zschäbitz, Jan Oldenburg, Dingwei Ye, Xun Lin, Cynthia G Healy, Nicola Di Santo, A Douglas Laird, Fabian Zohren, Archana M Agarwal
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial. Nature medicine (2023)
Mari Karimaa, Reetta Riikonen, Henna Kettunen, Päivi Taavitsainen, Meri Ramela, Marcin Chrusciel, Stefan Karlsson, Petteri Rummakko, Outi Simola, Gerd Wohlfahrt, Pasi Hakulinen, Annamari Vuorela, Heikki Joensuu, Tapio Utriainen, Karim Fizazi, Riikka Oksala
First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis. Molecular cancer therapeutics 21 (12) (2022)
Safae Terrisse, Anne-Gaelle Goubet, Kousuke Ueda, Andrew Maltez Thomas, Valentin Quiniou, Cassandra Thelemaque, Garett Dunsmore, Emmanuel Clave, Melissa Gamat-Huber, Satoru Yonekura, Gladys Ferrere, Conrad Rauber, Hang Phuong Pham, Jean-Eudes Fahrner, Eugenie Pizzato, Pierre Ly, Marine Fidelle, Marine Mazzenga, Carolina Alves Costa Silva, Federica Armanini, Federica Pinto, Francesco Asnicar, Romain Daillère, Lisa Derosa, Corentin Richard, Pierre Blanchard, Bertrand Routy, Stéphane Culine, Paule Opolon, Aymeric Silvin, Florent Ginhoux, Antoine Toubert, Nicola Segata, Douglas G McNeel, Karim Fizazi, Guido Kroemer, Laurence Zitvogel
Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer. Journal for immunotherapy of cancer 10 (3) (2022)
Maha H A Hussain, Michael A Carducci, Noel Clarke, Sarah E Fenton, Karim Fizazi, Silke Gillessen Sommer, Heather Jacene, Michael J Morris, Fred Saad, A Oliver Sartor, Mary-Ellen Taplin, Neha Vapiwala, Scott G Williams, Christopher J Sweeney
Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
Karim Fizazi, Margitta Retz, Daniel P Petrylak, Jeffrey C Goh, Jose Perez-Gracia, Louis Lacombe, Stefanie Zschäbitz, Mauricio Burotto, Hakim Mahammedi, Gwenaelle Gravis, Diogo Assed Bastos, Steven L McCune, Juan Carlos Vázquez Limón, Edmond M Kwan, Daniel Castellano, Aude Fléchon, Fred Saad, Marc-Oliver Grimm, David R Shaffer, Andrew J Armstrong, Prabhu Bhagavatheeswaran, Neha P Amin, Keziban Ünsal-Kaçmaz, Xuya Wang, Jun Li, Andrea Loehr, Russell K Pachynski
Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial. Journal for immunotherapy of cancer 10 (8) (2022)
Silke Gillessen Sommer, Nicolas Sauvé, Laurence Collette, Gedske Daugaard, Ronald de Wit, Costantine Albany, Alexey A Tryakin, Karim Fizazi, Olof Stahl, Jourik A Gietema, Ugo De Giorgi, Fay H Cafferty, Aaron Richard Hansen, Torgrim Tandstad, Robert A Huddart, Andrea Necchi, Christopher J Sweeney, Xavier García Del Muro Solans, Daniel Y C Heng, Anja Lorch, Michal Chovanec, Eric Winquist, Peter S Grimison, Darren R Feldman, Angelika Terbuch, Marcus Ulrich Hentrich, Carsten Bokemeyer, Helene F S Negaard, Christian Daniel Fankhauser, Jonathan Shamash, David J Vaughn, Cora N Sternberg, Axel Heidenreich, Joerg Beyer, null null
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)